Table 1 The clinicopathological features of all patients
From: Long non-coding RNA FAM83H-AS1 acts as a potential oncogenic driver in human ovarian cancer
No. | Age (year) | Tumor size (cm) | Lymph node metastasis | Stage | Pathological type | Treatment | ER positive cells (%) | PR positive cells (%) | WT-1 | P53 | KI67 (%) | MDR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 53 | R:13x13x10 | No | IA | Advanced serous adenocarcinoma of right ovary | No | 70 | <  5% | + | 3+ | 70 | + |
2 | 48 | L:4.5 × 3.5 × 2.0,R:7.5 × 4.5 × 3.0 | No | IIB | Advanced serous adenocarcinoma of bilateral ovary | No | 90 | 40 | – | 3+ | 60 | – |
3 | 43 | L:7x6x5,R:8x6x5 | Yes | IIB | Advanced serous adenocarcinoma of bilateral ovary | No | 70 | 30 | + | 2+ | 70 | – |
4 | 56 | L:8x7x7 | Yes | IIC | Advanced serous adenocarcinoma of left ovary | No | 90 | 5 | + | 3+ | 80 | – |
5 | 56 | L:8x7x6 | No | IA | Advanced serous adenocarcinoma of left ovary | No | 70 | – | + | 3+ | – | – |
6 | 53 | L:20x16x8 | No | IC | Advanced serous adenocarcinoma of left ovary | No | 50 | 10 | + | + | 30 | – |